Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia
- 1 April 2000
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 25 (8) , 843-851
- https://doi.org/10.1038/sj.bmt.1702337
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 45 references indexed in Scilit:
- Measurement of Residual Leukemia during Remission in Childhood Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1997
- The treatment of acute leukaemiaThe Lancet, 1997
- DETECTION OF DONOR-DERIVED CELLS BY POLYMERASE CHAIN REACTION IN NEONATALLY TOLERANT MICETransplantation, 1995
- Bone Marrow Transplants from HLA-Identical Siblings as Compared with Chemotherapy for Children with Acute Lymphoblastic Leukemia in a Second RemissionNew England Journal of Medicine, 1994
- Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysisBlood, 1994
- Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogeneic IgH probes and the polymerase chain reactionBlood, 1993
- Identification of the skeletal remains of a murder victim by DNA analysisNature, 1991
- Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantationBlood, 1991
- T-cell receptor delta gene recombination in common acute lymphoblastic leukemia: preferential usage of V delta 2 and frequent involvement of the J alpha clusterBlood, 1991
- Marrow transplantation for patients with acute lymphoblastic leukemia in remissionBlood, 1979